ANN SMITH: Open Payments
NPI 1700341294 · GERMANTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 108 payments from 20 companies in 2025. Trend: 2023 $383 · 2024 $899 · 2025 $1,847
Food & beverage: $1,767Education: $80
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $318 |
| Astellas Pharma US Inc | 6 | $213 |
| ABBVIE INC. | 14 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $140 |
| Amgen Inc. | 8 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| Lilly USA, LLC | 7 | $92 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Abbott Laboratories | 5 | $83 |
Products named: VRAYLAR, Ozempic, Kerendia, Veozah, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across OH — which companies pay providers there.
